Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Humira Competitors Don’t Guarantee Lower Patient Drug Costs
Will Humira Competitors Take Over the Immunology Drugs Market? - iData ...
Humira Competitors Have CVS Wrestling With Complex Calculations | Crain ...
Humira Drug Market Size, Competitors & Forecast to 2029
Low-cost Humira competitors hit the U.S. market
Low-Cost Humira Competitors Now Available | Newsmax.com
[News Focus] Abbvie hits back at competitors selling Humira biosimilars ...
AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira - WSJ
Comprehensive Humira Biosimilar List: Key Alternatives Explained
AbbVie's Humira gets a U.S. rival, but costs could stay high | Reuters
New Humira rivals likely to hit US market with small discounts in July ...
The Biosimilars That May Compete With Humira Starting Next Year
AbbVie's tight grip on Humira market raises concerns about biosimilars ...
A Review of Newly Available Humira Biosimilars for Pharmacists
What Do the Humira Biosimilar / Interchangeable Launches Mean for the ...
Entry of HUMIRA Biosimilars in Psoriatic Arthritis Treatment Market
Cardinal Health - Humira (Adalimumab) Biosimilar Comparison Report : r/CHRS
Pharmaceutical Strategies Group | PSG | First Humira Biosimilar Hits ...
Humira biosimilars: Five things to know | MDedge
AbbVie (ABBV): Dividend Safety Pressured By Humira - Dividend Power
Pharmacists’ Key Role in The Management of Humira Biosimilars
The Humira Case: Exploring the Blockbuster Ahead of United States ...
’Tis the Year of the Humira Biosimilars
Humira Biosimilars: Market Impact, Cost Savings, and Future Trends
AbbVie Expects to Weather Competition For Humira Blockbuster Drug ...
Humira (adalimumab) | The Pharmaceutical Accountability Foundation
Humira survives competition from adalimumab biosimilars - for now ...
Adalimumab competition to intensify in US due to launch of Humira ...
Blockbuster Arthritis Drug Humira Faces Competition From First Lower ...
Humira - the highest gross-selling drug in the world - isn't done yet ...
World’s biggest-selling drug company cheats competitors and consumers ...
A bellwether for biosimilars: Why the new competition for Humira ...
What You Need to Know About Humira's Low-Cost Competitors
Humira Patent Expiration: What's Next for its Biosimilars? - GreyB
Cheaper competition for Humira is hitting the market, but savings will ...
Humira vs. Amjevita: Similarities and Differences - Insulin Outlet
How Much Does Humira Cost? A Deep Dive On A Big Drug, 55% OFF
Humira lawsuits 2025 Updates: What You Need to Know
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar ...
Blockbuster drug Humira finally faces lower-cost rivals – WABE
After over 20 years of market exclusivity, Humira now faces biosimilar ...
AbbVie continues heavy spend on Humira TV ads as biosimilar competition ...
Abbott Laboratories Plans Changes For Arthritis Drug Humira - WSJ
Copycats take bite out of AbbVie’s best-selling Humira drug
Top Performing Drug of 2021 - Humira (April Edition) - PharmaShots
Best Alternatives for Humira
Blockbuster drug Humira has new competition. Here’s why that matters ...
Ready, Set, Go! The Early Dawn of Humira Biosimilars - IQVIA
AbbVie’s Humira exclusivity loss is a missed opportunity for ...
Humira should expect some indirect biosimilar competition from ...
Humira Market Size, Share & Trends | Industry Report, 2030
Humira | PPTX
Drug Channels: Humira Biosimilar Price War Update: Should We Be Glad ...
The Big Event: Humira Biosimilar Launches – Axene Health Partners, LLC
Exploring switching trends from Humira to approved biosimilars
Humira vs. Biosimilar: How we saved Indiana employers over $1 Billion ...
Drug Channels: Drug Channels News Roundup, June 2023: Humira Price War ...
Humira faces up to intense biosimilar competition
Humira competition an outlier as biosimilars seek global footing | BioWorld
[ANALYSIS] Korean Humira biosimilars set for huge 2023
AbbVie in Hot Water Over Patent Abuses and Price Hikes to Block Humira ...
AbbVie’s Humira loss of exclusivity has been a missed opportunity for ...
AbbVie posts weak sales of newer drugs as Humira faces fresh ...
Humira alternatives: What can I take instead of Humira? | SingleCare
Humira biosimilars became available in EU 10/18; and will soon be ...
Humira Overpricing | Hagens Berman
First Humira Biosimilar Hits the Market Today: Should We Be Excited ...
World’s best-selling drug Humira gains insurance coverage in Korea
Humira – a story of how positioning helped build a ‘pipeline in a product’
Scott Knoer on LinkedIn: Blockbuster Arthritis Drug Humira Faces ...
Humira Sales Grow as Competition Heats Up
Cardinal Health - Humira Biosimilar Comparison Report : r/shortedstockbets
Biosimilars make inroads into Humira sales; docs still cautious
AbbVie's blockbuster drug Humira finally loses its 20-year, $200 ...
KUOW - AbbVie's blockbuster drug Humira finally loses its 20-year, $200 ...
AbbVie is sued for using Humira patent deals to block competition in ...
Overview of Humira® biosimilars: current European landscape and future ...
Implications of the AVT02 (Humira Biosimilar) by Teva and Alvotech on ...
PPT - Jing Chen Hisham Haider Dewan Harout Sahakian PowerPoint ...
iData Medtech Newsletter
Biosimilar Competition Erodes Humira’s Market Share; Amjevita Leads the ...
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System ...
Humira's Market Dominance Amid Biosimilar Competition: A Closer Look ...
From Triumph to Competition: Humira's Journey and the Rise of ...
The End of the Billion-Dollar Drug
Biosimilar Cost Cutting: Saving on Humira, Remicade, and Stelara - GoodRx
Overview of Humira® Biosimilars: Current European Landscape and Future ...
NEW BRIEF: U.S. Patients Could Save Up to $5.8 Billion Through ...
EHR data research | Truveta
Rinvoq Prescription Access Through Patient Assistance Program (PAP)
AbbVie 2017: Humira, And What's Next - PharmaLive
From Triumph to Competition: Humira's Journey and the Rise of Biosimilars
Loss of Exclusivity: Generics Hit Fast, Biologics Hold Strong
Happy Birthday Adalimumab Biosimilars: Reflecting on the First Year of ...
Arthritis drug Humira's two-decade reign ends as Amgen launches ...
First look at US commercial health payers’ coverage of Amjevita™ shows ...
How Big Is The Biosimilar Threat To AbbVie's Humira? (NYSE:ABBV ...
What are the world's top selling drugs | PDF
8 Virtual Power Plant Companies and Startups - GreyB
Humira's US patent expiry heats up biosimilar competition
Humira's hold on market slips as CVS moves to biosimilar | Crain's ...
2018's best-sellers? AbbVie's Humira, obviously, but newcomers are on ...
:max_bytes(150000):strip_icc()/VWH-GettyImages-1432981236-d986fd9a1404404882302c16b3584399.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/VXP5FAFIRJOTZKPPV4FFRKSXYA.jpg)
